IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab.

Cancers (Basel) · 2022 · PMC8774131 · PMID 35053427

Europe PMC DOI

hedged sentence

0.0517

closest p · 1.0× alpha

0.0517

boldest claim

The sentences

did not reach statistical significancep = 0.0517so close (0.05 < p ≤ 0.1)

However, the association with shorter OS did not reach statistical significance (median, 5.08 vs. 10.13 months; HR, 2.49; 95% CI, 0.93–6.47; p = 0.0517) ( Figure 4 G–I).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.